Ingredient · Evidence grade C

S-equol for menopause: evidence, studies and safety

Last updated · 3 studies summarized

C Short answer: S-equol is a soy-derived compound (the active in Equelle) studied for occasional hot flashes and muscle aches associated with menopause*. Results are mixed, and the key trials were sponsored by companies behind the ingredient or product.

Key facts

Evidence gradeC C
Use studiedhot flashes, muscle/joint aches
Trials~5–6 RCTs (Daily 2019 MA: 6 studies, 779 women)
Participants779
What reviews concludeDaily 2019 MA: benefit on hot-flash scores, 3/5 trials positive, 2 null; most trials <50/group.
The Menopause Society (2023)Not recommended (Level II) – mixed evidence.
Also known asEquelle, SE5-OH, EQ

Grades: A strong · B moderate · C limited · D none or negative. How we grade.

Every study we reviewed

Each summary gives who took part, the dose, how long, the result compared with placebo or control, and who paid for it.

  • Equol Decreases Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

    Daily JW, Ko BS, Ryuk J et al. · J Med Food 2019 · S-equol

    An analysis of 6 trials found S-equol lowered hot-flash scores overall, but 2 of the 5 pooled trials found no benefit and most trials were small.

    Who
    6 RCTs, 779 women
    Dose
    S-equol or isoflavones in equol producers
    Duration
    various
    Result
    Pooled benefit on hot-flash scores; 3 of 5 trials positive, 2 null.
    Funding
    Academic (Korea); not stated as industry funded. Independent / academic

    PubMed · Full text (DOI)

  • A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women.

    Aso T, Uchiyama S, Matsumura Y et al. · J Womens Health (Larchmt) 2012 · S-equol

    160 Japanese women who could not make equol themselves took 10 mg S-equol or placebo for 12 weeks. Hot flashes fell about 59% vs 35% on placebo. The ingredient's maker ran the research, and Japanese women tend to have milder hot flashes than US women.

    Who
    160 Japanese equol non-producers (126 completed)
    Dose
    natural S-equol 10 mg/day
    Duration
    12 weeks
    Result
    Hot flushes -58.7% vs -34.5% placebo (P=.009); less neck/shoulder stiffness.
    Funding
    Otsuka Pharmaceutical (developer of the S-equol ingredient used in Equelle). Industry-linked

    PubMed · Full text (DOI)

  • A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency.

    Jenks BH, Iwashita S, Nakagawa Y et al. · J Womens Health (Larchmt) 2012 · S-equol

    The only US hot-flash trial of S-equol compared different doses with soy isoflavones, with no placebo group. All groups improved similarly; higher doses did slightly better. It was run by Pharmavite, which makes Equelle.

    Who
    102 US postmenopausal women
    Dose
    S-equol 10, 20 or 40 mg/day vs soy isoflavones (no placebo)
    Duration
    8 weeks
    Result
    Similar hot-flash reductions at week 8; 40 mg beat isoflavones on cumulative analysis; 10–20 mg better for muscle/joint pain.
    Funding
    Pharmavite LLC (Equelle maker) – lead author employee. Industry-linked

    PubMed · Full text (DOI)

Safety

Soy-derived; avoid with soy allergy. Breast-cancer-history safety not established for concentrated isoflavone products. US trial lacked placebo; most data in Japanese women.

Ranked products that contain it

Ranked products containing S-equol, by our score.
ProductAmount per dayScore$/day
Equelle Menopause Multi-Symptom ReliefS-equol: 10 mg47.4$1.40

FAQ

Does S-equol help with menopause symptoms?

S-equol is a soy-derived compound (the active in Equelle) studied for occasional hot flashes and muscle aches associated with menopause*. Results are mixed, and the key trials were sponsored by companies behind the ingredient or product. Our evidence grade is C. Daily 2019 MA: benefit on hot-flash scores, 3/5 trials positive, 2 null; most trials <50/group.

Does The Menopause Society recommend S-equol?

Not recommended (Level II) – mixed evidence. The 2023 nonhormone statement recommends no dietary supplement for hot flashes; talk to a clinician about hormone therapy and prescription options.

Is S-equol safe?

Soy-derived; avoid with soy allergy. Breast-cancer-history safety not established for concentrated isoflavone products. US trial lacked placebo; most data in Japanese women. Supplements are not FDA-approved before sale; ask a clinician or pharmacist, especially if you take medication.

Sources

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.